For example, the inactivation of NF1—a positive regulator of KRAS GTP to GDP transition—should shift KRAS proteins into their GTP-bound state and increase tumor number and/or growth in the KRAS G12C-, KRAS G12D- and EGFR-driven tumors. Here, KRAS is linked to neoplasm.